DB92

ICD-11 MMS 2026-01

Non-alcoholic fatty liver disease

Description

NAFLD is characterised by fatty liver related to insulin resistance in the absence of significant alcohol consumption. It embraces a pathological spectrum from simple steatosis to steatohepatitis. 10-20% of cases have steatohepatitis (non-alcoholic steatohepatitis: NASH), which can progress to cirrhosis and hepatocellular carcinoma.

Excludes

  • 1E51.1 – Chronic hepatitis C
  • 5C53 – inherited defects in mitochondrial metabolism
  • 8E46 – Reye syndrome
  • DB94 – Alcoholic liver disease
  • DB95 – Drug-induced or toxic liver disease
  • JA65.0 – Acute fatty liver of pregnancy

Exclusions from above levels

  • ME10.1 – Unspecified jaundice
  • 01 – Certain infectious or parasitic diseases
  • 02 – Neoplasms
Show allHide
  • 05 – Endocrine, nutritional or metabolic diseases
  • 06 – Mental, behavioural or neurodevelopmental disorders
  • 18 – Complications of pregnancy, childbirth and the puerperium
  • 22 – Injury, poisoning or certain other consequences of external causes

Child codes

  • DB92.0 – Non-alcoholic fatty liver disease without non-alcoholic steatohepatitis
  • DB92.1 – Non-alcoholic steatohepatitis
  • DB92.Y – Other specified non-alcoholic fatty liver disease
  • DB92.Z – Non-alcoholic fatty liver disease, unspecified

Sibling codes

  • DB90 – Infectious liver disease
  • DB91 – Acute or subacute hepatic failure
  • DB93 – Hepatic fibrosis or cirrhosis
  • DB94 – Alcoholic liver disease
  • DB95 – Drug-induced or toxic liver disease
  • DB96 – Autoimmune liver disease
  • DB97 – Certain specified inflammatory liver diseases
  • DB98 – Vascular disorders of the liver
  • DB99 – Certain specified diseases of liver
  • DB9Z – Diseases of liver, unspecified

Foundation entity

Non-alcoholic fatty liver disease – http://id.who.int/icd/entity/1912806631

Allowed postcoordination axes

Part of: 13: Diseases of the digestive system